Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (Q39506775)

12 September 2017

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (English)

1 reference

Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

12 September 2017

corrigendum / erratum

1 reference

13

Pier Paolo Pandolfi

0 references

Carlos Cordon-Cardo

series ordinal

11

object named as

Carlos Cordon-Cardo

1 reference

12 September 2017

7

Andrea Alimonti

1 reference

12 September 2017

4

Zhenbang Chen

1 reference

12 September 2017

1

Brett S Carver

1 reference

12 September 2017

8

Caterina Nardella

1 reference

12 September 2017

6

Arkaitz Carracedo

1 reference

12 September 2017

3

Anuradha Gopalan

1 reference

12 September 2017

5

Safa Shaikh

1 reference

12 September 2017

9

Shohreh Varmeh

1 reference

12 September 2017

Jennifer Tran

2

1 reference

12 September 2017

Peter T Scardino

series ordinal

10

1 reference

12 September 2017

William Gerald

series ordinal

12

1 reference

12 September 2017

language of work or name

English

0 references

publication date

26 April 2009

1 reference

12 September 2017

1 reference

12 September 2017

41

1 reference

12 September 2017

5

1 reference

12 September 2017

619-624

1 reference

Role of the TMPRSS2-ERG gene fusion in prostate cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

ADAMTS1 proteinase is up-regulated in wounded skin and regulates migration of fibroblasts and endothelial cells

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Pten dose dictates cancer progression in the prostate

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Pten is essential for embryonic development and tumour suppression

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835150

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

17 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038/NG.370

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038/NG.370

Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19396168

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NG.370

1 reference

Dimensions Publication ID

12 September 2017

1049961568

0 references

Fatcat ID

release_cm7dckkim5fm5hso4netddj6c4

0 references

1 reference

12 September 2017

PubMed publication ID

19396168

1 reference